Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 2048-2060
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2048
Variable | Odds ratio | 97.5%CI | P value |
CEA level before radiotherapy | |||
Normal range | 1 | ||
Elevated | 3.277 | 1.543-7.163 | 0.002 |
Post-treatment N | |||
N0 | 1 | ||
N+ | 2.437 | 1.143-5.308 | 0.022 |
HER2 | |||
- | 1 | ||
+ | 4.222 | 1.667-11.409 | 0.003 |
- Citation: Chen N, Li CL, Peng YF, Yao YF. Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study. World J Gastrointest Oncol 2022; 14(10): 2048-2060
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2048.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2048